Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
capecitabine
i
Other names:
R340, RG 340, RO 091978, Ro09-1978, RG340, RO091978, RO-091978
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(81)
News
Trials
Company:
Generic mfg.
Drug class:
Thymidylate synthase inhibitor
Related drugs:
‹
5-fluorouracil (143)
pemetrexed (58)
gimeracil/oteracil/tegafur (7)
raltitrexed (3)
arfolitixorin (2)
fluorouracil topical (1)
NUC-3373 (1)
tegafur/uracil (1)
pemetrexed (0)
TG6002 (0)
nolatrexed (0)
doxifluridine (0)
LY01616 (0)
levoleucovorin calcium (0)
DB107 (0)
5-fluorouracil (143)
pemetrexed (58)
gimeracil/oteracil/tegafur (7)
raltitrexed (3)
arfolitixorin (2)
fluorouracil topical (1)
NUC-3373 (1)
tegafur/uracil (1)
pemetrexed (0)
TG6002 (0)
nolatrexed (0)
doxifluridine (0)
LY01616 (0)
levoleucovorin calcium (0)
DB107 (0)
›
Associations
(81)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Colon Cancer
No biomarker
Colon Cancer
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
docetaxel + capecitabine
Sensitive: A1 - Approval
docetaxel + capecitabine
Sensitive
:
A1
docetaxel + capecitabine
Sensitive: A1 - Approval
docetaxel + capecitabine
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
No biomarker
Gastric Cancer
No biomarker
Gastric Cancer
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
No biomarker
Colorectal Cancer
No biomarker
Colorectal Cancer
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
capecitabine
Sensitive: A1 - Approval
capecitabine
Sensitive
:
A1
No biomarker
Oral Cancer
No biomarker
Oral Cancer
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
HER-2 negative
Gastric Cancer
HER-2 negative
Gastric Cancer
cisplatin + capecitabine
Sensitive: A2 - Guideline
cisplatin + capecitabine
Sensitive
:
A2
cisplatin + capecitabine
Sensitive: A2 - Guideline
cisplatin + capecitabine
Sensitive
:
A2
HER-2 negative
Gastroesophageal Junction Adenocarcinoma
HER-2 negative
Gastroesophageal Junction Adenocarcinoma
cisplatin + capecitabine
Sensitive: A2 - Guideline
cisplatin + capecitabine
Sensitive
:
A2
cisplatin + capecitabine
Sensitive: A2 - Guideline
cisplatin + capecitabine
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Gastroesophageal Junction Adenocarcinoma
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.